Koninklijke Philips N.V. (PHI1) Stock Price & Analysis
PHI1 Stock Chart & Stats
- Day’s Range
- EUR 24.13 - EUR 24.51
- 52-Week Range
- EUR 20.92 - EUR 27.57
- Previous Close
- EUR 24.17
- Volume
- N/A
- Average Volume (3M)
- 6,475
- Market Cap
- EUR 23.56B
- Enterprise Value
- EUR 28.72B
- Total Cash (Recent Filing)
- EUR 1.79B
- Total Debt (Recent Filing)
- EUR 7.46B
- Price to Earnings (P/E)
- 20.7
- Beta
- 1.08
- Next Earnings
- Nov 03, 2026 (Est.)
- EPS Estimate
- 0.34
- Last Dividend Ex-Date
- May 12, 2026
- Dividend Yield
- 3.52%
Bulls Say, Bears Say
Bulls Say
Operational Recovery
The return to positive earnings alongside double-digit TTM revenue growth indicates renewed demand and operating recovery after prior declines. A solid EBIT margin provides a base for reinvestment and service expansion, although durability still depends on consistent execution.
Manageable Leverage
Manageable leverage and equity exceeding total debt provide Philips with financial resilience while it funds product development and customer programs. Stable debt-to-equity over time also reduces the risk that normal operating volatility will sharply constrain strategic flexibility.
Recurring Healthcare Revenue
Philips combines equipment sales with maintenance, upgrades, software, consumables, and multi-year solution arrangements. This installed-base model can support repeat purchasing and recurring revenue, making customer relationships and cash generation more durable than one-time equipment sales alone.
Bears Say
Free Cash Flow Deterioration
The sharp decline in free cash flow growth weakens confidence that recent earnings are translating into steadily improving cash generation. Historically uneven cash flow, including negative operating and free cash flow in 2022, suggests conversion may remain vulnerable to working-capital or restructuring swings.
Earnings Volatility
The recovery in profitability is encouraging, but the recent loss-making period and five-year earnings volatility make current performance less clearly durable. Net and operating margins also remain below the 2021 peak, limiting confidence that the rebound represents a fully normalized earnings base.
Prior Balance-sheet Pressure
The decline in equity from 2021 and several years of negative returns show that earlier earnings pressure affected the balance sheet and shareholder returns. Although ROE has recovered, the recent turnaround still needs to persist before Philips can demonstrate consistently stronger capital productivity.
Koninklijke Philips N.V. News
PHI1 FAQ
What was Koninklijke Philips N.V.’s price range in the past 12 months?
What is Koninklijke Philips N.V.’s market cap?
When is Koninklijke Philips N.V.’s upcoming earnings report date?
How were Koninklijke Philips N.V.’s earnings last quarter?
Is Koninklijke Philips N.V. overvalued?
Does Koninklijke Philips N.V. pay dividends?
What is Koninklijke Philips N.V.’s EPS estimate?
How many shares outstanding does Koninklijke Philips N.V. have?
What happened to Koninklijke Philips N.V.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Koninklijke Philips N.V.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Koninklijke Philips N.V.
Koninklijke Philips N.V. operates as a leading global healthcare technology enterprise with a presence across North America and numerous international markets. Its operations are organized into three primary divisions: Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses. Within the Diagnosis & Treatment segment, Philips offers advanced diagnostic imaging technologies, including magnetic resonance (MRI), computed tomography (CT), X-ray systems, and innovative detector-based spectral CT solutions, alongside molecular and hybrid imaging for nuclear medicine. The company also provides integrated interventional systems and comprehensive echography (ultrasound) solutions, crucial for diagnosis, treatment planning, and guidance in areas like cardiology, general imaging, obstetrics/gynecology, and point-of-care settings. This segment is further supported by proprietary software platforms designed to facilitate diagnostics and interventions, as well as enterprise diagnostic informatics products and related services. The Connected Care division focuses on solutions for critical patient management, emergency response, and sleep and respiratory conditions. Additionally, it delivers electronic medical record (EMR) and broader care management platforms. For Personal Health, Philips provides a range of consumer products, encompassing oral hygiene solutions such as electric toothbrushes, brush heads, and interdental cleaning and teeth whitening systems. This segment also includes infant feeding and digital parenting solutions, along with male grooming and beauty devices. Philips actively pursues strategic collaborations to enhance its offerings, notably partnering with Ibex Medical Analytics Ltd. to jointly promote digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide. The company also maintains a strategic partnership agreement with NICO.LAB. Established in 1891 and headquartered in Amsterdam, the Netherlands, the company adopted its current name, Koninklijke Philips N.V., in May 2013, having previously operated as Koninklijke Philips Electronics N.V.
- Sector
- General
- Industry
- Medical - Devices
- CEO
- Roy W. O. Jakobs
- Employees
- 63,670
- Website
- www.philips.ca
- Address
- Philips Center, Amsterdam, NH, 1077 WV, NL
Koninklijke Philips N.V. (PHI1) Earnings & Revenues
PHI1 Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 14 | 2 | 6 |
| Technical Analysis | 2 | 2 | 6 |
| Moving Averages | 12 | 0 | 0 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| NL:PHARMPharming Group |











